Cholesterol Drug May Prevent Colon Cancer, National Surgical Adjuvant Breast & Bowel Project Study

Nylen Cancer Center -- A new National Cancer Institute (NCI) sponsored study evaluates the cholesterol drug, Rosuvastatin, (Crestor) as a treatment to reduce the risk of colon cancer. Rosuvastatin is a statin, a class of drugs that lower cholesterol. The study, titled, P-5: Statin Polyp Prevention Trial in Patients with Resected Colon Cancer, is being conducted by a network of cancer research professionals...